The SERVE-HF safety notice in clinical practice-experiences of a tertiary sleep center

In May 2015, the results of the SERVE-HF trial - addressing adaptive servoventilation (ASV) in chronic heart failure (CHF) patients with central sleep apnea (CSA) - prompted a field safety notice. It was recommended to identify CHF patients treated with ASV and to advise the discontinuation of the treatment. We aimed to analyze the identification process and effect of ASV discontinuation on affected patients.

http://ift.tt/2lMii6E